Security key
04280A100
ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR)
CUSIP: 04280A100
Q4 2017 13F Holders as of 31 Dec 2017
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 23,358,744
- Total 13F value
- $85,959,545
- Share change
- +8,301,346
- Put/Call ratio
- 37%
- SEC-reported price per share
- $3.68
- Number of holders
- 74
- Value change
- +$30,381,058
- Number of buys
- 46
- Number of sells
- 20
- Shares outstanding
- 141,328,976
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2017
Institutions
74
Top holders
10
ARWR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2018
Previous quarter: Q3 2017
ARROWHEAD PHARMACEUTICALS, INC. SEC filings
ARROWHEAD PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04280A100
Recent filing periods:
Ownership snapshot
Top reported holders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
OppenheimerFunds, Inc.
Disclosed value leader
OppenheimerFunds, Inc.
Comparable rows
15/15
Latest evidence
30 Sep 2017
13F
Lead comparable stake: 2.1%
Showing 1-6 of 15 holder rows.
Quick read
OppenheimerFunds, Inc. leads the comparable SEC ownership view at 2.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens OppenheimerFunds, Inc.'s linked filing trail.
Comparable ownership
Top 5
OppenheimerFunds, Inc.
2.1%
VANGUARD GROUP INC
2%
BlackRock Finance, Inc.
2%
MILLENNIUM MANAGEMENT LLC
0.9%
D. E. Shaw & Co., Inc.
0.69%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| OppenheimerFunds, Inc. |
13F
Company
|
2.1%
|
$12,990,000
3,000,000 shares
|
— | 30 Sep 2017 |
| VANGUARD GROUP INC |
13F
Company
|
2%
|
$12,524,000
2,892,265 shares
|
— | 30 Sep 2017 |
| BlackRock Finance, Inc. |
13F
Company
|
2%
|
$12,380,000
2,859,169 shares
|
— | 30 Sep 2017 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
0.9%
|
$5,508,000
1,272,138 shares
|
— | 30 Sep 2017 |
| D. E. Shaw & Co., Inc. |
13F
Company
|
0.69%
|
$4,208,000
971,768 shares
|
— | 30 Sep 2017 |
| ING GROEP NV |
13F
Company
|
0.57%
|
$3,500,000
808,229 shares
|
— | 30 Sep 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
74
Shares
23,358,744
Rows available
74
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
54
Q4 2017 holders
74
Holder diff
20
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 value | Q4 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend